Case Conference June 6th 2012
06-Jun-2012, Divisi Ginekologi Onkologi RSCM Case Conference
June 6th 2012
Resume
Ms. W, 18 yo
359-66-79, Jamkesda
Patient post laparotomy suboptimal debulking at Karawaci Hospital at November 2011 with post-op diagnosis: ovarian cancer st III C. PA result was Germ cell tumor, yolk sac type/endoderm sinus, with invasion to omentum, chronic appendicitis with acute exacerbation.
First came to RSCM on December 2011 with chief complain anuria since 1 week, Renal US was done and the result was bilateral hydronephrosis and solid mass in abdominal cavity.
Performed bilateral nefrostomy ( 5/12/2011)
BEP chemotherapy was done from December 2011 until February 2012.
BEP seri : 15th December 2011
25th January 2012
17th February 2012
Marriage history: not married yet
PA (1109841) result: Sinus endodermal tumor
Laboratoy (5/3/2012) :
Tumor marker
Pre-chemo : AFP : 54.390 à 347,5
LDH: 2.203 à 647
Ca-125 : 114,1 à 12,8
US examination (08/03/2012):
Conclusion:
Right hydronephrosis, minimal right pleural efussion,
Mass shrinken (61x47 mm) compaed to US exam on 12 Des 2011 (190x96 mm).
Ro Thorax : No abnormalty at lung and heart.
Consult to Pulmonology : Low risk
Consult to Anesthesia : ASA II
23/04/2012
Performed Laparotomy with operation procedure : Secondary debulking, debulking of tumor (Salpingoophorectomy sinistra), Total Omentectomy, with residu from ileum 4 x 4 x 1 cm and rectum 5 x 4 x 0,5 cm.
PA Result ( 24/4/2012 ) :
Histologycally correspond with endodermal sinus (residu?) to the tissue : left tumor, implant on bowel and rectum
USG ( May 25th 2012 )
Left adnexa with lobulated solid lesion size 19,8 x 10,6 x 17,6 cm suspected residif. No metastatic lesion in liver and lien.
Solid lesion on paraaorta size 6 cm suspected lymph node enlargement
Left renal with hydronephrosis grade I
No pleural effusion. Ascites (+).
May 28th 2012 à 4th chemotherapy (BEP), but during chemotherapy the patient went home by her own will
A/ Ovarian cancer residif post chemotherapy and suboptimal debulking
P/ Palliative care :
è 1. Length of life with chemotherapy
or
è 2. Quality of life
Berita Lainnya
13-Mar-2013,Divisi Ginekologi Onkologi RSCMCase Conference March 13th 2013
13-Mar-2013,Divisi Ginekologi Onkologi RSCM
Case Conference March 13th 2013
06-Mar-2013,Divisi Ginekologi Onkologi RSCM
Case Conference March 6th 2013
06-Mar-2013,Divisi Ginekologi Onkologi RSCM
Case Conference March 6th 2013
20-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 20th 2013
13-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 113th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
06-Feb-2013,Divisi Ginekologi Onkologi RSCM
Case Conference February 6th 2013
Index News